Cost-effectiveness of cyclooxygenase-2 inhibitors in chronic arthritis

被引：2

作者：

Pellissier, JM ^{[1
]}

Watson, DJ ^{[1
]}

Kong, SDX ^{[1
]}

Straus, WL ^{[1
]}

机构：

[1] Merck & Co Inc, West Point, PA 19486 USA

来源：

ANNALS OF INTERNAL MEDICINE | 2004年 / 140卷 / 09期

关键词：

D O I：

10.7326/0003-4819-140-9-200405040-00019

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：761 / 761

页数：1

共 6 条

[1]

Hawkey Christopher J., 1998, American Journal of Medicine, V104, p67S, DOI 10.1016/S0002-9343(97)00215-5

[2] Economic evaluation of rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs for the treatment of osteoarthritis [J].

Pellissier, JM ;

Straus, WL ;

Watson, DJ ;

Kong, SX ;

Harper, SE .

CLINICAL THERAPEUTICS, 2001, 23 (07) :1061-1079

[3]

Scheiman James, 1998, American Journal of Medicine, V105, p32S, DOI 10.1016/S0002-9343(98)00279-4

[4] MISOPROSTOL REDUCES SERIOUS GASTROINTESTINAL COMPLICATIONS IN PATIENTS WITH RHEUMATOID-ARTHRITIS RECEIVING NONSTEROIDAL ANTIINFLAMMATORY DRUGS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].

SILVERSTEIN, FE ;

GRAHAM, DY ;

SENIOR, JR ;

DAVIES, HW ;

STRUTHERS, BJ ;

BITTMAN, RM ;

GEIS, GS .

ANNALS OF INTERNAL MEDICINE, 1995, 123 (04) :241-249

[5]

Singh G., 1998, AM J MED, V105, p31S, DOI DOI 10.1016/S0002-9343(98)00072-2

[6] The cost-effectiveness of cyclooxygenase-2 selective inhibitors in the management of chronic arthritis [J].

Spiegel, BMR ;

Targownik, L ;

Dulai, GS ;

Gralnek, IM .

ANNALS OF INTERNAL MEDICINE, 2003, 138 (10) :795-806

← 1 →